lobbying_activities: 871794

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
871794	d6e183a0-8eff-44fc-992d-19e6a80c40c4	Q4	PRIME THERAPEUTICS	400339576	PRIME THERAPEUTICS	2009	fourth_quarter	INS	S. 1697 Affordable Health Choices Act S. 1796 America's Health Choices Act H.R. 1204 Community Pharmacy Fairness Act H.R. 3200 America's Affordable Health Choices Act H.R. 1427/S. 726 promoting Innovation and Access to Life Saving Medications Act H.R. 1549 Pathway for Biosimilars Act Health Care Reform, Follow-on Biologics, Pharmaceutical Benefits, Comparative Effectiveness Research, Public Plan Option, Pharmaceutical Pricing, Generic Pharmaceuticals, Health IT, Medicare Part D, Medicaid, Pharmacy Networks and Contracting	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE		18000	0	0	2010-01-18T12:00:55.087000-05:00